Risk factors for radiation-induced hypothyroidism: A literature-based meta-analysis

Cancer

Volumn 117, Issue 23, 2011, Pages 5250-5260

  Vogelius, Ivan R ^a   Bentzen, Søren M ^b   Maraldo, Maja V ^a   Petersen, Peter M ^a   Specht, Lena ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

hypothyroidism; radiation oncology; radiation tolerance; radiobiology; radiotherapy; thyroid stimulating hormone; thyroidectomy

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CAUCASIAN; DISEASE ASSOCIATION; FEMALE; HEAD AND NECK SURGERY; HIGH RISK POPULATION; HUMAN; HYPOTHYROIDISM; LYMPHANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION INDUCED HYPOTHYROIDISM; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SYSTEMATIC REVIEW; THYROID SURGERY;

DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; HYPOTHYROIDISM; MALE; RADIATION INJURIES; RADIOTHERAPY; RISK FACTORS;

EID: 81755162273     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26186     Document Type: Review

References (51)

1. Hancock SL, Cox RS, McDougall IR,. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med. 1991; 325: 599-605.
2. Hancock SL, McDougall IR, Constine LS,. Thyroid abnormalities after therapeutic external radiation. Int J Radiat Oncol Biol Phys. 1995; 31: 1165-1170.
3. Vaidya B, Pearce SH,. Management of hypothyroidism in adults. BMJ. 2008; 337: a801.
4. Felix H, Dupre N, Drape M, Court L,. [Long-term influence of radiotherapy for cancer of larynx on the appearance of myxedema.] Lyon Med. 1961; 93: 1043-1050.
5. Jereczek-Fossa BA, Alterio D, Jassem J, Gibelli B, Tradati N, Orecchia R,. Radiotherapy-induced thyroid disorders. Cancer Treat Rev. 2004; 30: 369-384. (Pubitemid 38744493)
6. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC,. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000; 160: 526-534. (Pubitemid 30112276)
7. Bhandare N, Kennedy L, Malyapa RS, Morris CG, Mendenhall WM,. Primary and central hypothyroidism after radiotherapy for head-and-neck tumors. Int J Radiat Oncol Biol Phys. 2007; 68: 1131-1139. (Pubitemid 47048569)
8. Lo Galbo AM, de Bree R, Kuik DJ, et al. The prevalence of hypothyroidism after treatment for laryngeal and hypopharyngeal carcinomas: are autoantibodies of influence? Acta Otolaryngol. 2007; 127: 312-317.
9. Diaz R, Jaboin JJ, Morales-Paliza M, et al. Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2010; 77: 468-476.
10. Diez P, Vogelius IS, Bentzen SM,. A new method for synthesizing radiation dose-response data from multiple trials applied to prostate cancer. Int J Radiat Oncol Biol Phys. 2010; 77: 1066-1071.
11. Bentzen SM, Tucker SL,. Quantifying the position and steepness of radiation dose-response curves. Int J Radiat Biol. 1997; 71: 531-542. (Pubitemid 27229750)
12. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L,. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006; 295: 676-680. (Pubitemid 43209069)
13. Higgins JP, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analyses. BMJ. 2003; 327: 557-560. (Pubitemid 37088507)
14. Review Manager (RevMan) [computer program]. Version 5.0. Copenhagen, Denmark: The Nordic Cochrane Centre, The Cochrane Collaboration; 2008.
15. Matlab [computer program]. R2007b. 15-8-2007. Natick, MA: MathWorks Inc.; 2007.
16. Bethge W, Guggenberger D, Bamberg M, Kanz L, Bokemeyer C,. Thyroid toxicity of treatment for Hodgkin's disease. Ann Hematol. 2000; 79: 114-118. (Pubitemid 30195607)
17. Brusamolino E, Baio A, Orlandi E, et al. Long-term events in adult patients with clinical stage ia-iia nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up. Clin. Cancer Res. 2006; 12: 6487-6493. (Pubitemid 44799722)
18. Bramswig J, Hoornig-Franz I, Riepenhausen M, Schellong G,. The challenge of pediatric Hodgkin's disease-where is the balance between cure and long-term toxicity? A report of the West German multicenter studies DAL-HD-78, DAL-HD-82 and DAL-HD-85. Leukemia Lymphoma. 1990; 3: 183-193.
19. Chin D, Sklar C, Donahue B, et al. Thyroid dysfunction as a late effect in survivors of pediatric medulloblastoma/primitive neuroectodermal tumors: a comparison of hyperfractionated versus conventional radiotherapy. Cancer. 1997; 80: 798-804. (Pubitemid 27339836)
20. Colevas AD, Read R, Thornhill J, et al. Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys. 2001; 51: 599-604.
21. Fein DA, Hanlon AL, Corn BW, Curran WJ Jr, Coia LR,. The influence of lymphangiography on the development of hypothyroidism in patients irradiated for Hodgkin's disease. Int J Radiat Oncol Biol Phys. 1996; 36: 13-18. (Pubitemid 26314147)
22. Garcia-Serra A, Amdur RJ, Morris CG, Mazzaferri E, Mendenhall WM,. Thyroid function should be monitored following radiotherapy to the low neck. Am J Clin Oncol. 2005; 28: 255-258. (Pubitemid 40800476)
23. Grande C,. Hypothyroidism following radiotherapy for head and neck cancer: multivariate analysis of risk factors. Radiother Oncol. 1992; 25: 31-36.
24. Ho AC, Ho WK, Lam PK, Yuen AP, Wei WI,. Thyroid dysfunction in laryngectomees-10 years after treatment. Head Neck. 2008; 30: 336-340. (Pubitemid 351480749)
25. Illes A, Biro E, Miltenyi Z, et al. Hypothyroidism and thyroiditis after therapy for Hodgkin's disease. Acta Haematol. 2003; 109: 11-17. (Pubitemid 41754742)
26. Kanti AR, Ranjan DA, Santanu P, Litan NB, Amitabh R,. Iatrogenc hypothyroidism: a consequence of external beam radiotherapy to the head & neck malignancies. J Cancer Res Ther. 2005; 1: 142-146. (Pubitemid 43511066)
27. Khoo VS, Liew KH, Crennan EC, D'Costa IM, Quong G,. Thyroid dysfunction after mantle irradiation of Hodgkin's disease patients. Australas Radiol. 1998; 42: 52-57. (Pubitemid 28085201)
28. Koontz BF, Kirkpatrick JP, Clough RW, et al. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications. J Clin Oncol. 2006; 24: 605-611. (Pubitemid 46630423)
29. Kumpulainen EJ, Hirvikoski PP, Virtaniemi JA, et al. Hypothyroidism after radiotherapy for laryngeal cancer. Radiother Oncol. 2000; 57: 97-101.
30. Liening DA, Duncan NO, Blakeslee DB, Smith DB,. Hypothyroidism following radiotherapy for head and neck cancer. Otolaryngol Head Neck Surg. 1990; 103: 10-13. (Pubitemid 20226125)
31. Mercado G, Adelstein DJ, Saxton JP, Secic M, Larto MA, Lavertu P,. Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma. Cancer. 2001; 92: 2892-2897.
32. Metzger ML, Hudson MM, Somes GW, et al. White race as a risk factor for hypothyroidism after treatment for pediatric Hodgkin's lymphoma. J Clin Oncol. 2006; 24: 1516-1521. (Pubitemid 46638772)
33. Moser EC, Noordijk EM, Carde P, et al. Late non-neoplastic events in patients with aggressive non-Hodgkin's lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials. Clin Lymphoma Myeloma. 2005; 6: 122-130.
34. Nair N, Advani SH,. Follow up of alterations in thyroid hormones and thyrotropin in patients of Hodgkin's disease given mantle radiation. J Assoc Physicians India. 1990; 38: 623-624.
35. Paulino AC,. Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy. Int J Radiat Oncol Biol Phys. 2002; 53: 543-547. (Pubitemid 34626491)
36. Peerboom PF, Hassink EA, Melkert R, DeWit L, Nooijen WJ, Bruning PF,. Thyroid function 10-18 years after mantle field irradiation for Hodgkin's disease. Eur J Cancer. 1992; 28A: 1716-1718.
37. Ricardi U, Corrias A, Einaudi S, et al. Thyroid dysfunction as a late effect in childhood medulloblastoma: a comparison of hyperfractionated versus conventionally fractionated craniospinal radiotherapy. Int J Radiat Oncol Biol Phys. 2001; 50: 1287-1294. (Pubitemid 32727807)
38. Tell R, Lundell G, Nilsson B, Sjodin H, Lewin F, Lewensohn R,. Long-term incidence of hypothyroidism after radiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004; 60: 395-400. (Pubitemid 39233456)
39. Thorp MA, Levitt NS, Mortimore S, Isaacs S,. Parathyroid and thyroid function five years after treatment of laryngeal and hypopharyngeal carcinoma. Clin Otolaryngol Allied Sci. 1999; 24: 104-108. (Pubitemid 29184672)
40. Turner SL, Tiver KW, Boyages SC,. Thyroid dysfunction following radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 1995; 31: 279-283.
41. Ulger S, Ulger Z, Yildiz F, Ozyar E,. Incidence of hypothyroidism after radiotherapy for nasopharyngeal carcinoma. Med Oncol. 2007; 24: 91-94.
42. Weissler MC, Berry BW,. Thyroid-stimulating hormone levels after radiotherapy and combined therapy for head and neck cancer. Head Neck. 1991; 13: 420-423.
43. Wu YH, Wang HM, Chen HH, et al. Hypothyroidism after radiotherapy for nasopharyngeal cancer patients. Int J Radiat Oncol Biol Phys. 2010; 76: 1133-1139.
44. Zakotnik B, Budihna M, Smid L, et al. Patterns of failure in patients with locally advanced head and neck cancer treated postoperatively with irradiation or concomitant irradiation with Mitomycin C and Bleomycin. Int J Radiat Oncol Biol Phys. 2007; 67: 685-690. (Pubitemid 46215868)
45. Kuten A, Lubochitski R, Fishman G, Dale J, Stein ME,. Postradiotherapy hypothyroidism: radiation dose response and chemotherapeutic radiosensitization at less than 40 Gy. J Surg Oncol. 1996; 61: 281-283. (Pubitemid 26117121)
46. Norris AA, Amdur RJ, Morris CG, Mendenhall WM,. Hypothyroidism when the thyroid is included only in the low neck field during head and neck radiotherapy. Am J Clin Oncol. 2006; 29: 442-445. (Pubitemid 44536023)
47. Sklar C, Whitton J, Mertens A, et al. Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab. 2000; 85: 3227-3232.
48. Marks LB, Bentzen SM, Deasy JO, et al. Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys. 2010; 76: S70-S76.
49. Macaskill P, Walter SD, Irwig L,. A comparison of methods to detect publication bias in meta-analysis. Stat Med. 2001; 20: 641-654. (Pubitemid 32166424)
50. Meadows AT, Friedman DL, Neglia JP, et al. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009; 27: 2356-2362.
51. Bentzen SM, Vaeth M, Pedersen DE, Overgaard J,. Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment ∥ now! Int J Radiat Oncol Biol Phys. 1995; 32: 1531-1534.